Ardent Health Partners ARDT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 97.5%-0.1pp | 97.5%-0.1pp | 97.6%0.0pp | 97.6%0.0pp | 97.6%0.0pp | |
| Net margin | 2.1%-0.1pp | 2.1%-1.1pp | 3.2%-0.9pp | 4.1%+0.4pp | 3.7%+0.2pp | |
| Returns | ||||||
| Return on equity | 10.7%-0.5pp | 11.2%-7.0pp | 18.3%-7.3pp | 25.6%+5.9pp | 19.7%-3.7pp | |
| Return on invested capital | 14.6%+5.2pp | 9.4%-11.1pp | 20.5%-2.3pp | 22.8%— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.3×0.0× | 1.2×0.0× | 1.3×0.0× | 1.3×— | —— | |
| Liquidity | ||||||
| Current ratio | 2.1×+0.2× | 2×-0.1× | 2.1×-0.1× | 2.1×0.0× | 2.1×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×-1.0× | 1.8×+0.9× | 0.9×0.0× | 0.9×-0.1× | 1×-1.1× | |
| Net debt / EBITDA | 1.1×-2.2× | 3.3×+2.4× | 1×0.0× | 1×-0.1× | 1.1×-1.9× | |
| Per Share | ||||||
| Book value per share | $9.43+3.6% | $9.11+3.8% | $8.77-1.1% | $8.87+6.1% | $8.35-2.0% | |
| Valuation | ||||||
| Market capitalization | $1.35B-27.8% | $1.26B-33.3% | $1.9B+0.5% | $1.89B-3.9% | $1.96B-19.5% | |
| Price / earnings | 10×+1.7× | 9.3×+0.1× | 9.2×+1.8× | 7.4×-1.3× | 8.7×-2.9× | |
| Price / sales | 0.2×-0.1× | 0.2×-0.1× | 0.3×0.0× | 0.3×0.0× | 0.3×-0.1× | |
| Price / book | 1×-0.6× | 1×-0.5× | 1.5×0.0× | 1.5×-0.2× | 1.7×-0.5× | |
| EV / EBITDA | 3.8×-0.5× | 5.9×+1.6× | 4.3×+0.3× | 4×-0.5× | 4.5×-2.8× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Ardent Health Partners's ratios come from?
- Every ratio is computed from Ardent Health Partners's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
